Larimar Therapeutics
LRMR
#8809
Rank
NZ$0.19 B
Marketcap
$3.12
Share price
-6.45%
Change (1 day)
-74.08%
Change (1 year)

EPS for Larimar Therapeutics (LRMR)

EPS in 2023 (TTM): -$1.53

According to Larimar Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.64. In 2022 the company made an earnings per share (EPS) of -$2.74 an increase over its 2021 EPS that were of -$5.29.

EPS history for Larimar Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.53-44.3%
2022-$2.74-48.15%
2021-$5.29-14.27%
2020-$6.17